BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1115 related articles for article (PubMed ID: 24506522)

  • 1. Toxicity and efficacy of carbon nanotubes and graphene: the utility of carbon-based nanoparticles in nanomedicine.
    Zhang Y; Petibone D; Xu Y; Mahmood M; Karmakar A; Casciano D; Ali S; Biris AS
    Drug Metab Rev; 2014 May; 46(2):232-46. PubMed ID: 24506522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes.
    Yan L; Zhao F; Li S; Hu Z; Zhao Y
    Nanoscale; 2011 Feb; 3(2):362-82. PubMed ID: 21157592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon-based drug delivery carriers for cancer therapy.
    Lim DJ; Sim M; Oh L; Lim K; Park H
    Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-graphene in biomedicine: theranostic applications.
    Yang K; Feng L; Shi X; Liu Z
    Chem Soc Rev; 2013 Jan; 42(2):530-47. PubMed ID: 23059655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety considerations for graphene: lessons learnt from carbon nanotubes.
    Bussy C; Ali-Boucetta H; Kostarelos K
    Acc Chem Res; 2013 Mar; 46(3):692-701. PubMed ID: 23163827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology for implantable sensors: carbon nanotubes and graphene in medicine.
    Wujcik EK; Monty CN
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(3):233-49. PubMed ID: 23450525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological Concerns of Engineered Nanosize Drug Delivery Systems.
    Mukherjee B; Maji R; Roychowdhury S; Ghosh S
    Am J Ther; 2016; 23(1):e139-50. PubMed ID: 24100254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials.
    Gupta N; Rai DB; Jangid AK; Kulhari H
    Curr Drug Metab; 2019; 20(6):506-532. PubMed ID: 30251600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon nanotubes: Properties, biomedical applications, advantages and risks in patients and occupationally-exposed workers.
    Lamberti M; Pedata P; Sannolo N; Porto S; De Rosa A; Caraglia M
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):4-13. PubMed ID: 25816400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells.
    Zhang Y; Ali SF; Dervishi E; Xu Y; Li Z; Casciano D; Biris AS
    ACS Nano; 2010 Jun; 4(6):3181-6. PubMed ID: 20481456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing in vivo toxicity of graphene materials: current methods and future outlook.
    Ma Y; Shen H; Tu X; Zhang Z
    Nanomedicine (Lond); 2014 Jul; 9(10):1565-80. PubMed ID: 25253502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro toxicity of carbon nanotubes, nano-graphite and carbon black, similar impacts of acid functionalization.
    Figarol A; Pourchez J; Boudard D; Forest V; Akono C; Tulliani JM; Lecompte JP; Cottier M; Bernache-Assollant D; Grosseau P
    Toxicol In Vitro; 2015 Dec; 30(1 Pt B):476-85. PubMed ID: 26381085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon Nanotubes in Biomedical Applications: Factors, Mechanisms, and Remedies of Toxicity.
    Alshehri R; Ilyas AM; Hasan A; Arnaout A; Ahmed F; Memic A
    J Med Chem; 2016 Sep; 59(18):8149-67. PubMed ID: 27142556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graphene-based nanomaterials for nanobiotechnology and biomedical applications.
    Krishna KV; Ménard-Moyon C; Verma S; Bianco A
    Nanomedicine (Lond); 2013 Oct; 8(10):1669-88. PubMed ID: 24074389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black.
    Ma-Hock L; Strauss V; Treumann S; Küttler K; Wohlleben W; Hofmann T; Gröters S; Wiench K; van Ravenzwaay B; Landsiedel R
    Part Fibre Toxicol; 2013 Jun; 10():23. PubMed ID: 23773277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-walled carbon nanotubes and graphene oxides induce autophagosome accumulation and lysosome impairment in primarily cultured murine peritoneal macrophages.
    Wan B; Wang ZX; Lv QY; Dong PX; Zhao LX; Yang Y; Guo LH
    Toxicol Lett; 2013 Aug; 221(2):118-27. PubMed ID: 23769962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graphene and carbon nanotubes activate different cell surface receptors on macrophages before and after deactivation of endotoxins.
    Lahiani MH; Gokulan K; Williams K; Khodakovskaya MV; Khare S
    J Appl Toxicol; 2017 Nov; 37(11):1305-1316. PubMed ID: 28485474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.